Financials

  • Market Capitalization 3.19 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-27.01
Relación precio/flujo de caja
13.99

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1656
RARE
Ultragenyx Pharmaceutical Inc. - Common Stock
32.35 USD-2.62%-9.96%+31.40%+10.26%3.19 B USD
1662
BEAM
Beam Therapeutics Inc. - Common Stock
31.26 USD+0.84%-13.60%+4.72%+46.49%3.22 B USD
1687
ELVN
Enliven Therapeutics, Inc. - Common Stock
51.44 USD+1.12%+1.22%+12.73%+148.98%3.13 B USD
1701
CLDX
Celldex Therapeutics, Inc. - Common Stock
38.68 USD+0.39%-0.31%+21.94%+42.00%3.04 B USD

Noticias